Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone
Titel:
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone
Auteur:
Cheson, Bruce D. Trask, Peter C. Gribben, John G. Dimier, Natalie Kimby, Eva Lugtenburg, Pieternella J. Thieblemont, Catherine Wassner-Fritsch, Elisabeth Launonen, Aino Sehn, Laurie H.